ALL PSYCHEDELIC AND PSYCHEDELIC STOCK NEWS

Psychedelic Drugs ‘Far Exceed’ Cannabis Investment Potential (CNBC)

Shark Tank’s Kevin O’Leary, Wesana (WSNAF) CEO Daniel Carcillo and director at Mass General Hospital’s Center for the Neuroscience of Psychedelics Dr....

Psychedelic Therapeutics Sector Outlook Released (Valhalla Ventures)

Valhalla Ventures backs visionary founders at the forefront of social and technological movements that younger generations care about most.

2021 Psychedelic Investor Guide Released.

Institutional Analyst Inc. announced the release of the 2021 Psychedelic Investor Guide on Monday, October 18th. The Psychedelic Investor Guide is the...

Psychedelic Investor TV

To appear on an upcoming episode on Psychedelic Investor TV in conjunction with New to the Street TV airing on News Max,...

Protected: 2021 Psychedelic Investor Guide – October

OPEN GUIDE Updated Monthly.. Did we miss your publicly traded company?...

Ketamine Testimonials On Local Nashville and Miami News. Lamar Odom on Good Morning America.

News Channel 5 Nashville. Ketamine infusions are being used to treat patients with severe depression. The medicine is also a treatment...

Pasithea Therapeutics (KTTA) Opens its First Ketamine Therapy Clinic in the United Kingdom

Pasithea Therapeutics recently raised $24 million at its initial public offering (“IPO”). The Company’s Common Stock began trading on The Nasdaq...

Ehave (EHVVF) To Conduct Ketamine Clinical Trial In Miami, Florida

"I believe that we are on the verge of curing, as opposed to simply treating, certain psychiatric maladies." Dr. Jeffrey Kamlet,...

18 Psychedelic Experts Presenting (Bios).

KCSA PSYCHEDELIC INVESTOR CONFERENCE PRESENTERS Awaken (AWKN) CEO Anthony Tennyson

KCSA Psychedelics Conference. Wednesday, October 13th.

The KCSA Psychedelics Conference features live presentations and speakers who will address the various investment opportunities in...

Psychedelic Stock Review Initiates Coverage on Ehave Inc.

Psychedelic Stock Review Initiates Coverage on Ehave Inc. MIAMI, Sept. 30, 2021 (GLOBE NEWSWIRE) -- Ehave, Inc. (OTC Pink:...

Interview: Great Interview With Cybin (CYBN) CEO Doug Drysdale.

https://youtu.be/JXNEmACes2U?t=605 Interview start at 10:00 mark. LIVE QUOTE It...

Conference: Replay of Advances in Mental Health. M-Vest & Maxim Group LLC.

One of the best Conferences we have viewed to date, and being on replay it can be viewed at your leisure and/or...

KetaDash

Ketamine at Home Treatments
RESEARCH

Most Popular

Psychedelic Drugs ‘Far Exceed’ Cannabis Investment Potential (CNBC)

Shark Tank’s Kevin O’Leary, Wesana (WSNAF) CEO Daniel Carcillo and director at Mass General Hospital’s Center for the Neuroscience of Psychedelics Dr....

Psychedelic Therapeutics Sector Outlook Released (Valhalla Ventures)

Valhalla Ventures backs visionary founders at the forefront of social and technological movements that younger generations care about most.

2021 Psychedelic Investor Guide Released.

Institutional Analyst Inc. announced the release of the 2021 Psychedelic Investor Guide on Monday, October 18th. The Psychedelic Investor Guide is the...

LARGE CAP PSYCHEDELIC STOCKS

PSYCHEDELIC FUNDS AND ETFS